13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks

Why this matters

Institutional and long-term care settings show up across Areas 1, 2 and 4: inpatient orders, after-hours access, emergency kits, automated dispensing cabinets and emergency-department take-home packs. Oregon regulates them in ORS 689.605 and the institutional rules of OAR 855-041 (the 6000–7000 series), checked on the Board's institutional self-inspection form.

Hospitals, drug rooms and penal institutions (ORS 689.605)

• A hospital or long-term care facility with a pharmacy and a pharmacist is subject to ORS chapter 689.
• When no pharmacist is in attendance, a registered nurse supervisor may withdraw drugs under the pharmacist's standing orders on a written prescriber order, as needed until pharmacy services resume. The Board may issue a special permit allowing the nurse supervisor to act on an oral order.
• An inpatient care facility without a pharmacy must have a drug room, supervised by a pharmacist and subject to Board rules. Withdrawals are recorded in the responsible pharmacist's records. Hospitals with drug rooms keep complete receipt, withdrawal and disposal records for legend drugs.
• In penal institutions, a pharmacist may delegate to a registered nurse the withdrawal of drugs from manufacturers' containers for administration. The pharmacist monitors compliance and performs DURs, under a Board-approved written agreement (ORS 689.605(7)).

After-hours access (OAR 855-041-6300 to -6310)

Only one designated, trained registered nurse supervisor per shift may access a night cabinet or the closed pharmacy. A practitioner's order must be in the chart first. A copy of the order is left with the source container or an identical unit dose for pharmacist verification. Each removal is recorded, and a pharmacist later confirms it with their initials and the date (section 12.3).

Inpatient labeling and repackaging (OAR 855-041-6270)

Inpatient labels show:

• The patient's name and location.
• The drug name and strength.
• The route, when needed for clarity.
• The manufacturer and lot number, or an internal code that references them.
• Any auxiliary labels, and the expiration date.

Repackaged unit doses, including individual oral syringes, show the name, strength, expiration date and manufacturer and lot (or internal code). The pharmacy documents everyone involved in repackaging, including the verifying pharmacist. A barcode or electronic label the pharmacy adds must be verified by a pharmacist before distribution.

Emergency kits and code carts (OAR 855-041-6420)

• A pharmacist verifies and documents the contents of each emergency kit. Emergency kits hold drugs needed for immediate therapeutic needs that are not available in time from any other authorized source, such as malignant-hyperthermia, stroke and rapid-sequence-intubation kits.
• Each kit or cart is locked and externally labeled with the name, strength and quantity of every drug and the kit's expiration date, which is the first-expiring drug. The list must be readable without breaking the lock. A list taped to an inner tray does not comply.

Automated dispensing cabinets and floor stock (OAR 855-041-6200, -6540, -6600)

• Written procedures require inspection of drug storage areas at least every two months. The inspection covers storage conditions, controlled-substance distribution and administration records, outdated drugs, temperatures and the integrity of emergency supplies.
• The PIC decides who may access each ADC and when to revoke access.
• Nurses and technicians may not return a drug to its ADC pocket, only to a designated return bin. A pharmacist reviews returned drugs before they go back into pharmacy inventory.
• A count confirmation ("blind count") is required every time a controlled-substance bin is accessed: loading, unloading, removing or inventorying. Discrepancy reconciliations are documented and supervised by a pharmacist.
• The hospital must account for all controlled substances: receipt to inventory, dispensing, administration, waste and returns. Many hospitals use surveillance analytics for this. Schedule II reconciliation every 31 days applies (OAR 855-115-0210).

Emergency-department take-home prepacks (OAR 855-041-6410)

• An ED prepack is limited to a 48-hour supply unless Board rule allows otherwise.
• The pharmacy's label includes:
  • The drug name, strength and number of units, with the manufacturer or distributor for a generic.
  • Cautionary information, and product identification if not in unit-of-use packaging.
  • The expiration date, and the hospital pharmacy's name, address and phone.
• Before handing it to the patient, the practitioner or nurse adds the patient name, directions, date, a unique number, the prescriber and their initials. They also complete the dispensing record. Nasal opioid antagonists are exempt from the label requirement (ORS 689.813).
• A pharmacist reviews the dispensing records within 24 hours, verifying the drug, strength and quantity and performing and documenting a DUR. If the pharmacy is closed, the review happens on the first day it reopens, within 72 hours.
• Dual-language labels must be available on request.

Long-term care and community-based care (OAR 855-041-7050 to -7060)

Pharmacies serving LTC or community-based care facilities, such as skilled nursing, assisted living, adult foster homes and inpatient hospice, must:

• Help set up and supervise the facility's policies for storage, distribution, administration and disposal, and for medication counseling.
• Provide emergency drug kits only where the facility's license allows. Access is limited to a designated licensed nurse acting on a practitioner's order.
• Follow the return and redispensing limits of OAR 855-041-1045, which allows unopened, tamper-evident drugs kept under consultant-pharmacist oversight to be redispensed.
• Mark Schedule II partial fills "LTCF patient" within the 60-day limit.

Pharmacists serving facilities as consultants follow OAR 855-115-0300 (section 6.1).

Exam scenario

At 1 a.m. an ED physician gives a discharged patient a prepack of cephalexin for a cellulitis infection. The prepack holds 48 hours of doses. The physician adds the patient's name, directions, date, a unique number, their name and initials, and records the dispensing. The hospital pharmacy opens at 7 a.m. A pharmacist reviews the record within 24 hours, verifying the drug, strength and quantity and documenting a DUR. If the hospital pharmacy were closed for the weekend, the review would happen the first day it reopened, no later than 72 hours after dispensing.